Pharmaceutical group ยท India
Aurobindo Pharma
A group of 32 companies with 1,272 medicines in 8 countries.
Group structure
32 companies in 9 countries
Loadingโฆ
Pharmaceutical group ยท India
A group of 32 companies with 1,272 medicines in 8 countries.
32 companies in 9 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1โ25 of 1,272
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Abacavir/Lamivudine Aurobindo 600/300 mg, filmomhulde tablettenFilmomhulde tablet | Abacavir, Lamivudine | Netherlands | Authorised | 2017 |
| ABACAVIR SULFATE AND LAMIVUDINE600mg base; 300mg ยท Tablet | Abacavir, Lamivudine | United States | Marketed | 2016 |
| Acebutolol Aurobindo 200 mg, filmomhulde tablettenFilmomhulde tablet | Acebutolol | Netherlands | Authorised | 2018 |
| Acebutolol Aurobindo 400 mg, filmomhulde tablettenFilmomhulde tablet | Acebutolol | Netherlands | Authorised | 2018 |
| Acenocoumarol Aurobindo 1 mg, tablettenTablet | Acenocoumarol | Netherlands | Authorised | 2022 |
| Acetylcysteรฏne Auro 200 mg, bruistablettenBruistablet | Acetylcysteine | Netherlands | Authorised | 2022 |
| Acetylcysteรฏne Auro 600 mg, bruistablettenBruistablet | Acetylcysteine | Netherlands | Authorised | 2022 |
| Acetylcysteรฏne hoesttabletten bruis Sanias 200 mg, bruistablettenBruistablet | Acetylcysteine | Netherlands | Authorised | 2012 |
| Acetylcysteรฏne hoesttabletten bruis Sanias 600 mg, bruistablettenBruistablet | Acetylcysteine | Netherlands | Authorised | 2016 |
| Acetylcysteรฏne hoesttabletten bruis Sanias 600 mg, bruistablettenBruistablet | Acetylcysteine | Netherlands | Authorised | 2012 |
| Acetylcysteรฏne Sanias 200 mg, poeder in sachetsPoeder voor oraal gebruik | Acetylcysteine | Netherlands | Authorised | 1992 |
| Acetylcysteรฏne Sanias 600 mg, bruistablettenBruistablet | Acetylcysteine | Netherlands | Authorised | 2016 |
| Acetylcysteรฏne Sanias 600 mg, poeder in sachetsPoeder voor oraal gebruik | Acetylcysteine | Netherlands | Authorised | 1995 |
| Acetylsalicylzuur Aurobindo cardio 80 mg, tablettenTablet | Acetylsalicylzuur | Netherlands | Authorised | 2002 |
| Acetylsalicylzuur Cardio Aurobindo 80 mg, dispergeerbare tablettenDispergeerbare tablet | Acetylsalicylzuur | Netherlands | Authorised | 2008 |
| Aciclovir Aurobindo 200 mg, tablettenTablet | Aciclovir | Netherlands | Authorised | 2019 |
| Aciclovir Aurobindo 400 mg, tablettenTablet | Aciclovir | Netherlands | Authorised | 2019 |
| Aciclovir Aurobindo 800 mg, tablettenTablet | Aciclovir | Netherlands | Authorised | 2019 |
| AFIRMELLE0.02mg; 0.1mg ยท Tablet | Ethinyl estradiol, Levonorgestrel | United States | Marketed | 2016 |
| Alendroninezuur Aurobindo 70 mg, tablettenTablet | Alendronic acid | Netherlands | Authorised | 2010 |
| Alfacalcidol Aurobindo 0,25 microgram zachte capsulesCapsule, zacht | Alfacalcidol | Netherlands | Authorised | 2017 |
| Alfacalcidol Aurobindo 0,5 microgram zachte capsulesCapsule, zacht | Alfacalcidol | Netherlands | Authorised | 2017 |
| Alfacalcidol Aurobindo 1 microgram zachte capsulesCapsule, zacht | Alfacalcidol | Netherlands | Authorised | 2017 |
| Alfuzosine HCl Aurobindo 10 mg, tabletten met verlengde afgifteTablet met verlengde afgifte | Alfuzosin | Netherlands | Authorised | 2012 |
| Alfuzosine HCl Aurobindo 2,5 mg, filmomhulde tablettenFilmomhulde tablet | Alfuzosin | Netherlands | Authorised | 2010 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 710 | 710 | 0 | CompaniesAll medicines |
| Romania | 219 | 0 | 219 | CompaniesAll medicines |
| Spain | 142 | 0 | 142 | CompaniesAll medicines |
| United States | 106 | 93 | 13 | CompaniesAll medicines |
| Brazil | 63 | 37 | 26 | CompaniesAll medicines |
| Saudi Arabia | 25 | 25 | 0 | CompaniesAll medicines |
| Canada | 5 | 5 | 0 | CompaniesAll medicines |
| Italy | 2 | 2 | 0 | CompaniesAll medicines |
Also in the registers of Colombia, Malaysia, Singapore, Sweden, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Fuente de la informaciรณn: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, https://dados.anvisa.gov.br/dados/CONSULTAS/EMPRESA_FISCALIZACAO_PRODUTO/TA_CONSULTA_CBPF_MEDICAMENTO_DETALHE.CSV; source modified Fri, 15 May 2026 07:52:35 GMT; acquired 2026-10-18T08:23:43.211112+00:00; original factual values retained, no endorsement.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Agรชncia Nacional de Vigilรขncia Sanitรกria (Anvisa), DATAVISA open-data register; source modification 2026-10-07, acquired 2026-10-07 UTC.
Licence: Brazil federal open-data reuse, Decreto 8777/2016, consolidated article 4 as amended by Decreto 9903/2019
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Report an error or request removalCorrections from the company itself are welcome.
Keep Aurobindo Pharmaโs medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callLicence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes, dataset i7cb-raxc, rowsUpdatedAt 1792152574, acquired 2026-10-26; original values retained.
Licence: CC BY-SA 4.0
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
AIFA, https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv, HTTP Last-Modified Mon, 26 Oct 2026 00:02:13 GMT, acquired 2026-10-26T09:43:33.749886+00:00; factual native values retained; exact row correspondence and projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sฤnฤtฤศii, Catalogul public naลฃional al preลฃurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Lรคkemedelsverket, Sweden, Fรถrvaringstemperatur och hรฅllbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Lรคkemedelsverket, Sweden, Lรคkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
U.S. Food and Drug Administration, Drugs@FDA API last updated 2026-10-23; full fixed 19-ID query acquired 2026-10-24T09:17:53.209180+00:00. Original facts retained; Prognia exact ID projection and later-reference resolution; no FDA endorsement.
Licence: openFDA factual NDC data, Creative Commons CC0 1.0 Universal / public domain, third-party and source-listing exceptions retained
Well-known pharmaceutical groups, each with all its companies.
Ranked by their number of medicines.